Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors

Toshihiko Doi, Haruyasu Murakami, A. Ohtsu, Nozomu Fuse, Takayuki Yoshino, Nobuyuki Yamamoto, Narikazu Boku, Yusuke Onozawa, C-P. Hsu, Kevin Gorski,

Cancer Chemotherapy and Pharmacology · 2010 · 49 citations · 24 references

Concepts

References

24